Overall survival benefit of pembrolizumab plus chemoradiotherapy for patients with high-risk locally advanced cervical cancer. Nierengarten MB. Cancer 2025;131:e35688.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Overall survival benefit of pembrolizumab plus chemoradiotherapy for patients with high-risk locally advanced cervical cancer. Cancer 2025;131:e35688.
PMID: 39829085